Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MicroRNA-155 Assay in Childhood Allergic Rhinitis with SLIT and Probiotics
NCT04603456Phase 4Completed
- Sponsor
- Zagazig University
- Start
- Sep 2018
- Primary completion
- Mar 2019
- Modality
- Live Biotherapeutic Products, Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phleum pratense extract and lactobacillus acidophilus in allergic rhinitis (AR) (3 arms), sponsored by Zagazig University. Primary endpoint: Total Nasal Symptom Score at 6 months. Started Sep 2018; status: completed.
02
Drugs
phleum pratense extractlactobacillus acidophilus
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04603456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04603456.